FDA Describes How It Used Reg Flexibility To Stem Drug Shortages

FDA in a new report to Congress says drug shortages have declined since 2011, but still remain a problem despite myriad efforts by the agency to prevent them. The report lays out several types of regulatory flexibility used by the agency to prevent or stem drug shortages in 2017. The new report comes as a bipartisan group of senators urges FDA to convene a task force created by the 2012 Food and Drug Administration Safety and Innovation Act, which would...